close

Unlocking tomorrow's cures European Parliament, Brussels

Between 22 - 25 May 2018, EFPIA is organising an exhibition in the European Parliament entitled “Unlocking Tomorrow’s cures.” The exhibition is kindly sponsored by MEP Lieve Wierinck and supported by MEPs Adina Valean and Françoise Grossetête.

During this week, you will have the opportunity to discover our exhibition which will take you through a journey of past and upcoming breakthrough innovations and you will have an opportunity to learn more about how medical innovation works through our escape room games. EFPIA and its membership will also organise several lightening workshops in the exhibition area, which will be a great occasion for you to get a view on both challenges and success stories in R&D of new medicines and therapies that our industry is faced with everyday. You will also get a view on the life-changing innovations that have been brought to patients over the past few years and on what therapies that are in the pipeline and that will reach patients in the next few years.

We would be delighted if you could join us for the following events during the week:

Launch Reception
Tuesday, 22 May 2018, 18h30 to 20h00, Members’ Salon ASP G0

We are delighted to invite you to join us for the launch of the exhibition “Unlocking tomorrow’s Cures” taking place in Members’ Salon (ASP G0) from 18h30 to 20h00. During this networking evening, you will have an opportunity to also find out more about the exhibition space and the events we are planning throughout the week.

Plenary Event "Driving innovation in health: How does Europe remain a global leader in life sciences?”

Thursday, 24 May, 16h30 to 18h30, room PHSB001

We are delighted to invite you to our plenary event “Driving innovation in health: How does Europe remain a global leader in life sciences?” taking place in the European Parliament on 24 May in room PHS B001. The event is kindly hosted by MEP Lieve Wierinck together with MEP Adina Valean and MEP Françoise Grossetête

The pharmaceutical industry is on the cusp of delivering ground-breaking treatments for patients. From CAR-T to cell therapies and the HIV vaccine, innovative therapies have the potential to revolutionise patients’ lives. As an audience participant, you will get a multi-stakeholder perspective on key drivers for innovation in life sciences, and what policies are needed to sustain and deliver innovative treatments for patients.

During a series of “fireside chats” we will discuss the following themes:

  • How collaboration in research can advance development of treatments and accelerate patients’ access to innovative therapies.
  • What is the role of incentives in sustaining innovation in healthcare in Europe
  • How we can further empower patients to contribute to the innovation and medicines development process
  • How we can introduce future innovations into healthcare systems in a sustainable way

The discussions have been set up to be interactive. You are encouraged to participate throughout the discussion either by asking a question on Twitter (#healthinnovationEU or @EFPIA) or by submitting written questions on paper in a fishbowl that will circulate within the room.

Programme:
16h30 – 16h45: Welcome from sponsoring MEPs – Lieve Wierinck (ALDE, Belgium), Adina Vălean (EPP, Romania) & Françoise Grossetête (EPP, France)
16h45 – 16h55: Setting the scene and explaining the format – Elizabeth Kuiper, EFPIA Public Affairs Executive Director
16h55 – 17h15: How collaboration in research can advance development of treatments and accelerate patients’ access to innovative therapies
MEP Lieve Wierinck (ALDE, Belgium) & Salah-Dine Chibout, Global Head of Discovery & Investigative Safety / Global Head of Therapeutic Areas (TAs) at Novartis Pharma AG
17h15 – 17h35: What is the role of incentives in sustaining innovation in healthcare in Europe
Yann Le Cam (Eurordis) & MEP Adina Vălean - TBC (EPP, Romania)
17h35 – 17h55: How we can further empower patients to contribute to the innovation and medicines development process
Matthew May (EUPATI Coordinator) & Tony Hoos (Amgen & PFMD - patient focused medicines development)
17h55 – 18h15: How we can introduce future innovations into healthcare systems in a sustainable way
Olga Solomon (DG SANTE, Head of Unit B5 Medicines: policy, authorisation and monitoring) & Fredrik Moen (IHE- The Swedish Institute for Health Economics)
18h15 – 18h30: Concluding remarks

Two days of Workshops 
Wednesday & Thursday 23 - 24 May, Exhibition Space, 3rd floor European Parliament

Day 1: Pharmaceutical innovations that changed our lives forever

The first day of workshops/interactive sessions will provide members with the opportunity to demonstrate some of the amazing innovations that the pharmaceutical industry have brought to market and have drastically changed patient outcomes.

9h45 - Welcome, EFPIA
10h00 - Oncology innovations shaping the present and the future
- Immuno-Oncology: A new chapter in cancer treatment, Nathan Vastesaeger, Executive Director Medical Affairs Oncology - Europe, Middle East and Africa, MSD
- Histology-independent development in rare tumors, Chitkala Kalidas, PhD, Vice President Head Oncology Regulatory Affairs, Bayer
11h00 - Stroke treatment, Joanne van Ryn (Senior Medical Advisor, Boehringer Ingelheim International Germany)
12h00 - Prospects, advantages and challenges of innovative vaccines, Mel Kohn (Medical Director, Vaccines Europe, MSD)
14h00 - CAR-T - breaking frontiers in hematology, Simona Paratore (MD, Head of Medical Cell & Gene Therapy Oncology Region Europe, Novartis)
15h00 - Making medicines that children can take – the challenges of paediatric formulation, Alastair Coupe (Senior Director, Pfizer Pharmaceuticals)
16h00 - Cardiovascular burden of disease, Nancy Cook Bruns, MD, Vice President, Cardiovascular Development, Bayer


Day 2: How will innovation change our medicine in the next decade?

The second day would serve to highlight the huge medical advances in the pharmaceutical pipeline that will completely change health outcomes for Europeans in the next decade. More future focused, these workshops will aim to foster an open debate on the challenges our healthcare systems face, the opportunities for progress & how we can ensure the pharmaceutical industry has the regulatory framework it needs in order to continue investment.

9h45 -  Welcome, EFPIA
10h00 - Real World Data Platforms and Disease Interception - Martine Lewi (Scientific Director Clinical Innovation R&D, Janssen)
11h00 - Vaccines of the future (mRNA) - Kim Schmidt (Senior Research Scientist, CureVac)
12h00 - U-CART immunotherapy -  Florence Binlich (MD, Deputy Director Development Oncology, Servier)
13h00 - Migraine & CGRP: A new era for patients - Jan Versijpt - (Head of Headache center at Brussels University Hospital, on invitation of Teva)
14h00 - Integrated Approaches in Diabetes Care – The 4 “D’s” - Jochen Maas (General Manager R&D, Sanofi Germany)
15h00 - Stem cell potential and tissue engineering - Diego Ardigó (R&D Rare Diseases Unit Head at Chiesi Farmaceutici)

/